Deafness: Clinical Trials

3 trials for Deafness, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Terminated 3
Phase 22Terminated 2

Follow Deafness: new trials by email Literature Review of Deafness trials Research Report on Deafness

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste)
QR-421a, Sham-procedure - Retinitis Pigmentosa, Usher Syndrome Type 2
Phase 2 / Phase 3TerminatedLaboratoires Thea52021-12-152024-08-07
Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius)
Ultevursen, Sham-procedure - Retinitis Pigmentosa, Usher Syndrome Type 2
Phase 2 / Phase 3TerminatedLaboratoires Thea72021-12-082024-07-12
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
AM-111 0.4 mg/ml, AM-111 0.8 mg/ml, Placebo - Hearing Loss, Idiopathic Sudden Sensorineural
Phase 3TerminatedAuris Medical, Inc.562016-06-012020-08-07

Narrower conditions

Eye Abnormalities (2)  ·  Eye Diseases (2)  ·  Eye Diseases, Hereditary (2)  ·  Retinal Diseases (2)  ·  Retinitis Pigmentosa (2)  ·  Usher Syndromes (2)  ·  Vision Disorders (2)  ·  Ear Diseases (1)  ·  Hearing Disorders (1)  ·  Hearing Loss (1)  ·  Hearing Loss, Sensorineural (1)  ·  Hearing Loss, Unilateral (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (3)  ·  Abnormalities, Multiple (2)  ·  Blindness (2)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Deaf-Blind Disorders (2)  ·  Ear Diseases (2)  ·  Genetic Diseases, Inborn (2)  ·  Hearing Disorders (2)  ·  Hearing Loss (2)  ·  Hearing Loss, Sensorineural (2)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Otorhinolaryngologic Diseases (2)

Interventions

Intravitreal Injections (2)  ·  D-JNKI-1 (1)

Sponsors

Laboratoires Thea (2)  ·  Auris Medical, Inc. (1)

Countries

United States (3)  ·  United Kingdom (2)  ·  Canada (1)  ·  Germany (1)  ·  Netherlands (1)  ·  South Korea (1)

Top investigators

Thomas Meier (1)